Else Nutrition Holdings Inc. (TSX:BABY)
Canada
· Delayed Price · Currency is CAD | Market Cap | 1.98M |
| Revenue (ttm) | 6.03M |
| Net Income (ttm) | -8.88M |
| Shares Out | 49.43M |
| EPS (ttm) | -0.26 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 351,000 |
| Average Volume | 151,940 |
| Open | 0.0400 |
| Previous Close | 0.0400 |
| Day's Range | 0.0400 - 0.0400 |
| 52-Week Range | 0.0400 - 0.4000 |
| Beta | 1.12 |
| RSI | 29.08 |
| Earnings Date | Mar 31, 2026 |
About Else Nutrition Holdings
Else Nutrition Holdings Inc. focuses on the research, development, manufacturing, marketing, and sale of plant-based food and nutrition products for infants, toddlers, children, and adults in Israel. The company offers a variety of products, including baby snacks, baby feeding accessories such as feeding bottles and teats, infant formula with plant-based nutrition for babies and toddlers, nutrition products for toddlers, children, and adults, complementary food products, and drinks for toddlers. It provides its products through online. Else Nut... [Read more]
Financial Performance
In 2025, Else Nutrition Holdings's revenue was 6.03 million, a decrease of -24.43% compared to the previous year's 7.97 million. Losses were -8.88 million, -41.51% less than in 2024.
Financial StatementsNews
Else Nutrition Commends Trump Administration's Expanded Commitment to Bolstering Infant Formulas Regulation in FY2027
President's Budget requested significant FDA funding increases, signaling growing support for Else's next-generation plant-based infant formula Builds Upon FY26 Congressional Appropriations Directive ...
Else Nutrition Holdings Transcript: Investor Summit Virtual Conference
A pioneering plant-based infant nutrition provider highlighted its financial turnaround, regulatory breakthroughs, and strong market positioning. FDA engagement and legislative changes are paving the way for potential U.S. approval, with profitability targeted by early 2027.
Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards
Updated FDA Framework Bolsters Scientific Validation Pathway for Else's Plant‑Based Formula and Accelerates U.S. Commercialization Potential VANCOUVER, BC, March 10, 2026 /PRNewswire/ - ELSE NUTRITION...
Else Nutrition Surpasses One Million Cans Sold Since Launch
Milestone underscores accelerating consumer demand for clean, dairy-free nutrition alternatives VANCOUVER, BC, Jan. 29, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTC: BABYF) (FS...
Else Nutrition Announces Results from Annual General Meeting of Shareholders
VANCOUVER, BC, Jan. 12, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) (the "Company") announces that at its annual general meeting of shareholders held on Dece...
Else Nutrition Plans Canadian Market Relaunch in 2026
Strategic Re-Entry Expected to Generate CAD$500,000 in Initial-Year Revenue VANCOUVER, BC, Jan. 7, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. ( BABY) ( BABYF) (0YL0) ("Else" or the "Company")...
Else Nutrition Announces Appointment of Natie Zilberberg as Chief Financial Officer
VANCOUVER, BC, Jan. 5, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTC: BABYF) (FSE: 0YL) (the "Company") is pleased to announce that it has appointed Natie Zilberberg as the Chief F...
Else Nutrition Achieves Transformative Operational and Financial Progress in 2025
Poised to Enter 2026 with Strengthened Momentum, FDA Breakthrough for a Clear Approval Pathway, and a Streamlined Path Toward Cash-Flow Breakeven VANCOUVER, BC , Dec. 17, 2025 /PRNewswire/ - ELSE NUTR...
ELSE NUTRITION ANNOUNCES FURTHER EXTENSION OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
VANCOUVER, BC , Dec. 12, 2025 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCPINK: BABYF) (FSE: 0YL) (the "Company") announces that further to its news releases dated June 19, 2025 and Au...
Else Nutrition CEO to Present at Investor Summit Virtual on December 9, 2025
VANCOUVER, BC / ACCESS Newswire / December 4, 2025 / ELSE NUTRITION HOLDINGS INC. (TSX: BABY)(OTC PINK: BABYD) ("Else" or the "Company"), a global pioneer in whole-food, plant-based nutrition for ba...
Else Nutrition Secures Five-Year Renewal of Israel's Largest Health Fund Tender for Baby Feeding Solutions
Winning Five-Year Health Tender Reinforces Else's Leadership in Hospital-Grade Infant Feeding Accessories VANCOUVER, BC , Dec. 2, 2025 /PRNewswire/ - Else Nutrition Holdings Inc. (TSX: BABY) (OTC: BAB...
Else Nutrition Announces Major Breakthrough: President Trump Signs Pivotal FDA Funding Package that Includes Congressional Directive Streamlining Regulatory Pathway for Non-Dairy, Non-Soy Plant-Based Infant Formula
New Federal Budget Agreement Ends Government Shutdown and Expedites FDA Pathway for Innovative, Non-Soy, Plant-Based Infant Nutrition Under Operation Stork Speed VANCOUVER, BC , Nov. 18, 2025 /PRNewsw...
Else Nutrition Holdings Earnings Call Transcript: Q3 2025
Gross margin surged to 34% in Q3 2025, with operating expenses down 68% year-over-year and monthly cash burn below $200,000. Revenue dipped due to temporary supply issues, but demand remains strong and the company targets cash flow break-even by late 2026 to early 2027.
Else Nutrition Reports Significant Operational Turnaround in Q3 2025 with Gross Margin Expansion and Cost Reduction
Conference call to be held on Monday, November 17 at 10:00 AM Eastern Time VANCOUVER, BC , Nov. 14, 2025 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), t...
Else Nutrition Reschedules 2025 Third Quarter Business Update Conference Call
Conference Call will Now be Held on Monday, November 17 th at 10:00 AM Eastern Time VANCOUVER, BC , Nov. 13, 2025 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Com...
Else Nutrition Schedules 2025 Third Quarter Business Update Conference Call
VANCOUVER, BC , Nov. 13, 2025 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), today announced that it plans to host a business update conference call at 1...
ELSE NUTRITION ANNOUNCES SHARE CONSOLIDATION
Vancouver, BC , Nov. 3, 2025 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) (the "Company") announces that the Company's board of directors has approved a consolidat...
Else Nutrition Holdings Earnings Call Transcript: Q2 2025
Q2 2025 saw revenue decline due to inventory constraints, but significant cost reductions led to a narrower net loss. Regulatory progress and international expansion efforts continue, with a focus on achieving cash flow break even by late 2026 or early 2027.
Else Nutrition Reports 2025 Second Quarter Financial Results and Provides Business Update
Conference call to be held today at 10:00 AM Eastern Time VANCOUVER, BC , Sept. 16, 2025 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC.
Else Nutrition Schedules 2025 Second Quarter Business Update Conference Call
VANCOUVER, BC , Sept. 11, 2025 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC.
Else Nutrition Holdings Earnings Call Transcript: Q1 2025
Q1 2025 saw flat revenues but sharply improved gross margins and reduced operating losses, driven by cost controls and operational efficiencies. U.S. retail presence expanded, while Canadian sales faced setbacks from inventory shortages. Regulatory changes are expected to benefit future product approvals.
Else Nutrition Reports 2025 First Quarter Financial Results and Provides Business Update
Conference call to be held today at 10:00 AM Eastern Time VANCOUVER, BC , Aug. 21, 2025 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ("Else" or the "Company"), t...
Else Nutrition Schedules 2025 First Quarter Business Update Conference Call
VANCOUVER, BC , Aug. 19, 2025 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ("Else" or the "Company"), today announced that it plans to host a business update co...
Else Nutrition Applauds Pivotal U.S. Legislative Support for Plant-Based, Non-Soy, Non-Dairy Infant Formula Innovation
House Appropriations Committee Champions Greater Nutritional Choice and Market Access for U.S. Families FDA Directed to Streamline Approval Pathways for Plant-Based Infant Formulas, Positioning Else N...
ELSE NUTRITION ANNOUNCES DELAY IN FILING FINANCIAL STATEMENTS AND EXTENSION OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
VANCOUVER, BC , June 19, 2025 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) (the "Company") announces that the Company's principal regulator in Canada, the British ...